Davenport Balanced Income holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Davenport Balanced Income Fund DBALX
- NAV / 1-Day Return $13.66 / −0.07 %
- Fund Size $277.2M
- Adjusted Expense Ratio 0.930%
- Net Expense Ratio 0.920%
- Fee Level: Distribution Above Average
- Share Class Type No Load
- Morningstar Category Moderate Allocation
- Equity Style Box (Funds) Large Value
- Fixed-Income Style Box (Funds) —
- Investment Status Open
- TTM Yield 2.66%
- Turnover Ratio 36%
Morningstar’s Analysis DBALX
Will DBALX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Treasury Obligs X | 2.93 | 8M | Cash and Equivalents |
Johnson & Johnson | 2.05 | 6M | Healthcare |
SLB Ltd | 1.87 | 5M | Energy |
Federal Farm Credit Banks 4.94% | 1.72 | 5M | Government |
Meta Platforms Inc 4.95% | 1.72 | 5M | Corporate |
Federal Farm Credit Banks 5% | 1.71 | 5M | Government |
Federal Farm Credit Banks 5.03% | 1.71 | 5M | Government |
Berkshire Hathaway Inc Class B | 1.70 | 5M | Financial Services |
Federal Farm Credit Banks 5.33% | 1.69 | 5M | Government |
Abbott Laboratories 4.65% | 1.67 | 5M | Corporate |